Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Department of Parmacy, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
Eur J Pharmacol. 2024 May 5;970:176461. doi: 10.1016/j.ejphar.2024.176461. Epub 2024 Mar 7.
Our previous studies have showed that sulfatide-reactive type II NKT (i.e. variant NKT, vNKT) cells inhibit the immunogenic maturation during the development of mature lung dendritic cells (LDCs), leading todeclined allergic airway inflammation in asthma. Nonetheless, the specific immunoregulatory roles of vNKT cells in LDC-mediated Th2 cell responses remain incompletely understood. Herein, we found that administration of sulfatide facilitated the generation of CD4FoxP3 regulatory T (Treg) cells in the lungs of wild-type mice, but not in CD1d and Jα18 mice, after ovalbumin or house dust mite exposure. This finding implies that the enhancement of lung Treg cells by sulfatide requires vNKT cells, which dependent on invariant NKT (iNKT) cells. Furthermore, the CD4FoxP3 Treg cells induced by sulfatide-reactive vNKT cells were found to be associated with PD-L1 molecules expressed on LDCs, and this association was dependent on iNKT cells. Collectively, our findings suggest that in asthma-mimicking murine models, sulfatide-reactive vNKT cells facilitate the generation of lung Treg cells through inducing tolerogenic properties in LDCs, and this process is dependent on the presence of lung iNKT cells. These results may provide a potential therapeutic approach to treat allergic asthma.
我们之前的研究表明,硫酸脑苷脂反应性 II 型 NKT(即变异 NKT,vNKT)细胞抑制成熟肺树突状细胞(LDC)发育过程中的免疫原性成熟,导致哮喘中过敏气道炎症的减轻。尽管如此,vNKT 细胞在 LDC 介导的 Th2 细胞反应中的特定免疫调节作用仍不完全清楚。在此,我们发现,在卵清蛋白或屋尘螨暴露后,硫酸脑苷脂促进了野生型小鼠肺部 CD4FoxP3 调节性 T(Treg)细胞的生成,但在 CD1d 和 Jα18 小鼠中则没有。这一发现表明,硫酸脑苷脂增强肺部 Treg 细胞需要 vNKT 细胞,而 vNKT 细胞又依赖于不变型 NKT(iNKT)细胞。此外,我们发现,硫酸脑苷脂反应性 vNKT 细胞诱导的 CD4FoxP3 Treg 细胞与 LDC 上表达的 PD-L1 分子有关,这种关联依赖于 iNKT 细胞。总的来说,我们的研究结果表明,在模拟哮喘的小鼠模型中,硫酸脑苷脂反应性 vNKT 细胞通过诱导 LDC 产生耐受特性,促进肺部 Treg 细胞的生成,这一过程依赖于肺部 iNKT 细胞的存在。这些结果可能为治疗过敏性哮喘提供一种潜在的治疗方法。